Overview

Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and tolerance of a dipyridamole/adenosine combination given intravenously, as a slow bolus and at low doses to adenosine alone (given at its recommended dosage adjusted to patients' weight) for coronary flow reserve assessment (in 60-75 patients with stable ischemic heart disease) using transthoracic echodoppler
Phase:
Phase 2
Details
Lead Sponsor:
Adenobio N.V
Treatments:
Adenosine
Dipyridamole